News
For children, yes, the CDC’s “shared decision-making” guidance preserves the status quo in which Medicaid and U.S.
Dr. Marty Makary, the Johns Hopkins surgeon and professor who, Trump tapped to lead the FDA, clarified the recently changed ...
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...
The Food and Drug administration has approved a new COVID-19 vaccine made by Moderna but with limits on who can use it.
The US Department of Health and Human Services, under Secretary Robert F. Kennedy Jr., has recently made significant changes ...
Panel members had questions about whether a new FDA proposal to require randomized trials for vaccines in healthy adults ...
Federal health officials have pulled back a key recommendation that pregnant women get the COVID-19 vaccine -- causing sharp ...
Health Secretary Robert F. Kennedy Jr. recently announced more key changes to the CDC recommendations for COVID-19 ...
Health Secretary Robert F. Kennedy Jr.’s decision to revoke the Covid vaccine recommendation for pregnant women has raised ...
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...
A Phase III trial demonstrated mNEXSPIKE’s non-inferior efficacy compared with Moderna’s original COVID vaccine, Spikevax.
The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results